• Contact Us
  • Sign Up
  • TWITTER
Microbiome Times Magazine
  • Pharma & Human Health
  • Animal Health
  • Phytobiome
  • Finance
    • Finance Articles
    • Microbiome Stocks
  • Events
  • Advertise
  • Multimedia
News Ticker
  • [ June 20, 2018 ] CosmosID Demonstrates Industry-Leading Performance for Strain-Level Microbiome Analysis in MOSAIC Challenge and PrecisionFDA Challenge Pharma & Human Health
  • [ December 13, 2019 ] Princeton researchers listen in on the chemical conversation of the human microbiome Pharma & Human Health
  • [ December 10, 2019 ] RB and Evolve BioSystems Team Up to Advance Infant Gut Health Finance
  • [ December 9, 2019 ] Investigating the human intestinal mucus barrier up-close and personal Pharma & Human Health
  • [ December 4, 2019 ] Da Volterra Announces Positive Results of a Phase 1 Drug-Drug Interaction Study Pharma & Human Health
  • [ November 27, 2019 ] Caelus Health and Nestlé Health Science sign exclusive global development & option agreement Finance
HomeEditor’s Choice

Editor’s Choice

Editor's Choice

5-Minute Microbiome Science Roundup: March 2019

April 1, 2019 Kristina Campbell

March saw the publication of many excellent scientific publications related to different aspects of the microbiome. Here’s a 5-minute roundup of 5 recent papers worth knowing about. A Weaning Reaction to Microbiota Is Required for […]

Editor's Choice

Intellectual Property Considerations for the Microbiome: Personalized Strategies for a Diverse Space

March 25, 2019 Scott Siera

While the microbiome space is often compared to the traditional pharmaceutical and biotechnology industries, the scientific, regulatory, and marketing strategies for microbiome products and platforms often differ from those centered on a single small molecule or large […]

Editor's Choice

Health for Life Capital II™, World Leading Microbiome-focused Fund Announces its First Close

March 5, 2019 Staff Editor

Seventure Partners, one of Europe’s leaders in financing innovation and a world-leader in life science microbiome investment, announces it has completed the first closing of its second dedicated fund focused on the microbiome, and health, […]

Editor's Choice

Here’s What Happened at Probiota, 13-15 February in Copenhagen

March 1, 2019 Nina Vinot

Probiota Copenhagen 2019 broke a new record, going from 250 attendees last year to 350 and sold out! Why? Because of its unique approach to bringing together stakeholders from the industry, the academy, CROs and […]

Editor's Choice

Jeffrey Gordon wins the Frontiers of Knowledge Award for pioneering microbiome research

February 14, 2019 Staff Editor

The BBVA Foundation Frontiers of Knowledge Award in the Biology and Biomedicine category has gone in this eleventh edition to American researcher Jeffrey Gordon, for his fundamental discovery of the importance of the gut microbial […]

Editor's Choice

More than 100 new gut bacteria discovered in human microbiome

February 8, 2019 Staff Editor

Scientists working on the gut microbiome* have discovered and isolated more than 100 completely new species of bacteria from healthy people’s intestines. The study from the Wellcome Sanger Institute, Hudson Institute of Medical Research, Australia, […]

Editor's Choice

Modelling Holobiont Evolution for a Better Understanding of Symbiosis, Dysbiosis, and Human Health

February 3, 2019 Kristina Campbell

The list of presentations from any recent microbiome conference shows the diversity of approaches by which scientists are pursuing discovery of microbiome-focused therapeutics. And common to all of these approaches is the essential need to […]

Editor's Choice

Biotech Focus: An Interview with Ken Blount, CSO, Rebiotix

January 7, 2019 Staff Editor

In just a few short years, Rebiotix has taken the concept of “bugs as drugs” and turned it into actual practice, constructing a standardized, stabilized drug product from the broad consortia of microbes present in a […]

Editor's Choice

EMA Rules On Omega-3 Medicinal Products – Useful Parallels for the Pharmabiotics Industry

December 21, 2018 Dr. Magali Cordaillat-Simmons (PhD)

On 13 December 2018, the European Medicines Agency (EMA) released the following statement: “Omega-3 fatty acid medicines are no longer considered as effective in preventing heart disease.” As several communications have been published by multiple […]

Editor's Choice

Pharmabiotics Young Investigator Awards: Supporting Tomorrow’s Microbiome Opinion Leaders

November 22, 2018 Staff Editor

The successful introduction of the 2018 Pharmabiotics Young Investigator Awards set the stage for its development as one of the most important and prestigious awards for young microbiome researchers.  Co-initiated by the Pharmabiotic Research Institute […]

Editor's Choice

6th Microbiome R&D and Business Collaboration Forum USA Summary

November 20, 2018 Anusha Gandhi

This summary of the 6th R&D and Business Collaboration Forum was authored by Anusha Gandhi from Microbiome Insights. The original version can be found here on their blog Leaders in the microbiome industry met in San […]

Posts navigation

« 1 … 3 4 5 »

Sign Up to Free Newsletter

August 2019 Issue is now Out:

Advertisments

Editor’s Choice

  • 5-minute Microbiome Science Roundup: October 2019
    November 18, 2019
  • Million Microbiome of Humans Project (MMHP) is launched, aiming to build the world’s largest human microbiome database
    November 9, 2019

Latest Headlines

Princeton researchers listen in on the chemical conversation of the human microbiome

  • RB and Evolve BioSystems Team Up to Advance Infant Gut Health

  • Investigating the human intestinal mucus barrier up-close and personal

  • Da Volterra Announces Positive Results of a Phase 1 Drug-Drug Interaction Study

  • Caelus Health and Nestlé Health Science sign exclusive global development & option agreement

  • Princeton researchers listen in on the chemical conversation of the human microbiome
  • RB and Evolve BioSystems Team Up to Advance Infant Gut Health
  • Investigating the human intestinal mucus barrier up-close and personal
  • Da Volterra Announces Positive Results of a Phase 1 Drug-Drug Interaction Study
  • Caelus Health and Nestlé Health Science sign exclusive global development & option agreement
  • TargEDys, a French microbiome start-up, collects the award for “Best Nutraceutical Product of the Year”
4D Pharma animal microbiome cancer Cholestoral chr hansen Cosmos ID DuPont IBD Industry Academia Industry Academic Partnerships innovation Live Biotherapeutics microbiome Microbiotica Optibiotix phage probiotics Strategic Collaboration synlogic Synthetic Biologics
No comments found
Categories
  • Animal Health
  • Editor's Choice
  • Finance
  • Pharma & Human Health
  • Phytobiome & Environment
  • Sponsored Content
  • Video
  • Webinar
sign up

Sign up to the Microbiome Times newsletter